Using IVR to Maintain ACS Patients on Best Practice Guidelines

Acute Coronary Syndrome Clinical Trial

— IVR-ACS BPG  

Official title:

Using Interactive Voice Response to Improve Disease Management and Compliance With Acute Coronary Syndrome Best Practice Guidelines

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01260207
• Other study ID #: R-07-391
• Status: Terminated
• Phase: Phase 3
• First received: December 13, 2010
• Last updated: August 25, 2017
• Start date: January 2010
• Est. completion date: December 15, 2014

Study information

• Verified date: March 2017
• Source: Lawson Health Research Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether interactive voice response (IVR) technology can be used to bring post discharge care for acute coronary syndrome (ACS) closer to best practice guidelines (BPGs).

The study hypothesis is that ACS patients who are contacted by IVR technology will be more likely to receive care as recommended in the BPGs than those followed by usual care.

Description:

Acute coronary syndrome (ACS) is a significant public-health problem in Canada and worldwide with 20,000 Canadians dying of myocardial infarction and 42,000 dying of coronary artery disease in 1999. Large clinical trials have provided evidence for the development of standardized best practice guidelines (BPG) and compliance with these guidelines have significantly improved survival. Despite the development and dissemination of BPG, their application in patients with ACS is suboptimal. This randomized control trial will use 2 groups: IVR and usual care. Patients in the IVR group will receive 5 automated calls at 1,3,6,9 and 12 months consisting of predetermined questions related to medication management, smoking cessation, diet, exercise and education as recommended by the ACC/AHA BPG for ACS. Responses are captured in a database allowing for interventions to maintain patients on BPG as needed.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 654
• Est. completion date: December 15, 2014
• Est. primary completion date: December 15, 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients discharged from LHSC with ACS (acute myocardial infarction, STEMI, NSTEMI or unstable angina)

• Patients who have a land line telephone service at home

• Patients who speak English

Exclusion Criteria:

• Patients discharged to a care facility or transferred to another health care institution

• Patients who cannot provide informed consent

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• Medication Adherence
• Syndrome

Intervention

Other:
• IVR group
Patients in this arm will receive IVR follow-up telephone calls at 1,3,6,9 and 12 months post-discharge consisting of predetermined questions related to medication management, smoking cessation, diet, exercise and education as recommended by the ACC/AHA BPG for ACS. Upon completion of the IVR follow-up, all patients will be called by a member of the clinical research staff and asked to complete a follow-up survey.

Locations

Country	Name	City	State
Canada	London Health Sciences Centre	London	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
Lawson Health Research Institute	Ottawa Heart Institute Research Corporation

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Compliance with BPGs		1 Year
Secondary	Utilization of health care resources: emergency visits, unscheduled physician visits and hospitalization and patient satisfaction		1 Year